Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease

Respiratory Research

Volumn 13, Issue , 2012, Pages

  van den Berge, Maarten ^a   Hop, Wim C J ^b   van der Molen, Thys ^a   van Noord, Jan A ^c   Creemers, Jacques P H M ^d   Schreurs, Ad J M ^e   Wouters, Emiel F M ^f   Postma, Dirkje S ^a   Aalbers, R ^g   Beaumont, F ^g   Boersma, W ^g   Bogaard, J ^g   Bunnik, M ^g   Creemers, J ^g   Dalinghaus, W ^g   de Graaff, C ^g   de Jong, J ^g   de Jong, P ^g   de Munck, D ^g   de Vries, D ^g   de Vries, I ^g   den Hertog, W ^g   Dik, H ^g   Dubois, E ^g   Eland, M ^g   Evers, W ^g   Gans, S ^g   Geraedts, W ^g   Heijerman, H ^g   Hendriks, A ^g   Ho, ^g   Hol, B ^g   Kersbergen, J ^g   Los, H ^g   Luursema, P ^g   Pannekoek, B ^g   Pieters, W ^g   Quanjel, R ^g   Quanjel Wisselo, E ^g   Rammeloo, R ^g   Retera, J ^g   Roldaan, A ^g   Rudolphus, A ^g   Sala, L ^g   Schlosser N ^g   Schols, A ^g   Schreurs, A ^g   Simons, J ^g   Sips, A ^g   Smeenk, F ^g   Strankinga, W ^g   Utama, I ^g   van Beek, F ^g   van de Woude, H ^g   van den Berg, P ^g   van den Bosch, J ^g,g   van der Brink, W ^g   van den Elshout, F ^g   van der Bruggen Bogaarts, B ^g   van der Zeijden, J ^g   van Harreveld, A ^g   van Keimpema, A ^g   van Noord, J ^g   van Pagee H ^g   van Snippenburg, R ^g   van Spiegel, P ^g   Verbraecken, J ^g   Westbroek, J ^g   more..

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Sittard Geleen Heerlen   (Netherlands)

^d CATHARINA HOSPITAL   (Netherlands)

^e JEROEN BOSCH HOSPITAL   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g University Hospital Maastricht ^*

Author keywords

CCQ; COPD; Exacerbations; Symptoms

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL; SALBUTAMOL; SALMETEROL; ANDROSTANE DERIVATIVE; BRONCHODILATING AGENT; DRUG DERIVATIVE; FLUTICASONE; FLUTICASONE, SALMETEROL DRUG COMBINATION; GLUCOCORTICOID;

ADULT; AROUSAL; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PREDICTION; PREDICTOR VARIABLE; SPUTUM; AGED; CLINICAL TRIAL; DRUG COMBINATION; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; TIME; TREATMENT WITHDRAWAL;

AGED; ALBUTEROL; ANDROSTADIENES; BRONCHODILATOR AGENTS; DISEASE PROGRESSION; DRUG COMBINATIONS; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; TIME FACTORS; WITHHOLDING TREATMENT;

EID: 84861809353     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-13-44     Document Type: Article

References (17)

1. Fabbri LM, Hurd SS. Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Respir J 2003, 22(1):1-2. 10.1183/09031936.03.00063703, 12882441.
2. Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002, 57(10):847-852. 10.1136/thorax.57.10.847, 1746193, 12324669.
3. Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 2001, 164(3):358-364.
4. Soler-Cataluna JJ, Martinez-Garcia MA, Roman SP, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005, 60(11):925-931. 10.1136/thx.2005.040527, 1747235, 16055622.
5. Tattersfield AE, Postma DS, Barnes PJ, et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations The FACET International Study Group. Am J Respir Crit Care Med 1999, 160(2):594-599.
6. Jones PW, Willits LR, Burge PS, et al. Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations. Eur Respir J 2003, 21(1):68-73. 10.1183/09031936.03.00013303, 12570111.
7. Calverley P, Pauwels DR, Lofdahl CG, et al. Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Eur Respir J 2005, 26(3):406-413. 10.1183/09031936.05.00143404, 16135720.
8. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157(5 Pt 1):1418-1422.
9. Seemungal TA, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 161(5):1608-1613.
10. Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care 2003, 48(12):1204-1213.
11. Kocks JW, Tuinenga MG, Uil SM, et al. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res 2006, 7:62. 10.1186/1465-9921-7-62, 1508149, 16603063.
12. Van der Molen T, Willemse BW, Schokker S, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003, 1:13. 10.1186/1477-7525-1-13, 156640, 12773199.
13. Osman IM, Godden DJ, Friend JA, et al. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997, 52(1):67-71. 10.1136/thx.52.1.67, 1758400, 9039248.
14. Wouters EF, Postma DS, Fokkens B, et al. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial. Thorax 2005, 60(6):480-487. 10.1136/thx.2004.034280, 1747438, 15923248.
15. Partridge MR, Karlsson N, Small IR. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin 2009, 25(8):2043-2048. 10.1185/03007990903103006, 19569976.
16. Postma DS, Keyzer JJ, Koeter GH, et al. Influence of the parasympathetic and sympathetic nervous system on nocturnal bronchial obstruction. Clin Sci (Lond) 1985, 69(3):251-258.
17. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010, 363(12):1128-1138. 10.1056/NEJMoa0909883, 20843247.